Gujarat Kidney & Super Speciality IPO Price: ₹108 to ₹114 per share
IPO Dates: 22nd December 2025 – 24th December 2025

Company Overview
Incorporated in 2019, Gujarat Kidney and Super Speciality Limited (GKASSL) is a multispeciality healthcare provider offering secondary and tertiary care services across multiple locations in Gujarat, India.
Hospital Network & Infrastructure
The company operates seven multispeciality hospitals and four pharmacies, with:
- Total bed capacity: 490 beds
- Approved bed capacity: 455 beds
- Operational bed capacity: 340 beds
Hospital Locations
GKASSL’s hospital network includes:
- Gujarat Kidney and Superspeciality Hospital, Vadodara
- Gujarat Multispeciality Hospital, Godhra
- Raj Palmland Hospital Private Limited, Bharuch
- Surya Hospital and ICU, Borsad
- Gujarat Surgical Hospital, Vadodara
- Ashwini Medical Centre, Anand
The company also operates Ashwini Medical Store in Anand.
Healthcare Services Offered
Secondary Care Services
- General medical treatments
- Surgical procedures
Tertiary Care Services
- Super speciality surgical procedures
Clinical Specialities
Gujarat Superspeciality Hospital provides treatment across multiple specialities, including:
- Internal medicine
- General surgery
- Minimally invasive procedures
- Orthopaedics and trauma care
- Joint replacement surgery
- Obstetrics and gynaecology
- Respiratory care
- Non-interventional cardiology
- Diabetology
- Anaesthesiology
Medical & Support Staff
As of June 30, 2025, the company employed:
- 89 doctors
- 332 nurses
- 338 other staff members
Competitive Strengths
- Strong presence in renal sciences, with established sub-specialities in urology
- Asset-light business model focused on central Gujarat
- Ability to attract and retain skilled medical professionals
- Proven track record of operational and financial growth
Bidding Starts In
Gujarat Kidney & Super Speciality IPO Specifics:
| IPO Date | Mon, Dec 22, 2025 to Wed, Dec 24, 2025 |
| Face Value | ₹2 per share |
| Price Band | ₹108 to ₹114 per share |
| Lot Size | 128 Shares |
| Sale Type | Fresh Capital |
| Total Issue Size | 1,84,89,583 shares 2,20,00,000 shares (aggregating up to ₹250.80 Cr) |
| Issue Type | Bookbuilding IPO |
| Listing At | BSE, NSE |
| Share Holding Pre Issue | 5,68,43,250 shares |
| Share Holding Post Issue | 7,88,43,250 shares |
Gujarat Kidney & Super Speciality IPO Timetable (Important Dates)
| IPO Open Date | Mon, Dec 22, 2025 |
| IPO Close Date | Wed, Dec 24, 2025 |
| Tentative Allotment | Fri, Dec 26, 2025 |
| Initiation of Refunds | Mon, Dec 29, 2025 |
| Credit of Shares to Demat | Mon, Dec 29, 2025 |
| Listing Date | Tue, Dec 30, 2025 |
| Cut-off time for UPI mandate confirmation | 5 PM on Wed, Dec 24, 2025 |
Gujarat Kidney & Super Speciality IPO Lot Size
Bidders have the opportunity to bid for a minimum of 128 shares, with the option to increase in multiples. The table below outlines the minimum and maximum investment thresholds for both retail investors and High Net Worth Individuals (HNIs), specifying the corresponding number of shares and amounts involved.
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 1 | 128 | ₹14,592 |
| Retail (Max) | 13 | 1,664 | ₹1,89,696 |
| S-HNI (Min) | 14 | 1,792 | ₹2,04,288 |
| S-HNI (Max) | 68 | 8,704 | ₹9,92,256 |
| B-HNI (Min) | 69 | 8,832 | ₹10,06,848 |
Gujarat Kidney & Super Speciality IPO Reservation
| QIB Shares Offered | Not less than 75% of the Issue |
| Retail Shares Offered | Not more than 10% of the Issue |
| NII (HNI) Shares Offered | Not more than 15% of the Issue |
Gujarat Kidney & Super Speciality IPO Financial Information
| Period Ended | 30 Jun 2025 | 31 Mar 2025 | 31 Mar 2024 | 31 Mar 2023 |
|---|---|---|---|---|
| Assets | 61.59 | 55.34 | 20.53 | 3.87 |
| Total Income | 15.27 | 40.40 | 5.48 | 0.00 |
| Profit After Tax | 5.40 | 9.50 | 1.71 | -0.01 |
| EBITDA | 8.63 | 16.55 | 1.95 | -0.01 |
| NET Worth | 30.56 | 25.71 | 10.80 | 0.37 |
| Reserves and Surplus | 19.42 | 14.57 | 10.60 | 0.17 |
| Total Borrowing | 4.03 | 3.88 | 1.94 | 120.35 |
Key Performance Indicator – Gujarat Kidney & Super Speciality IPO
| KPI | Values |
|---|---|
| ROE | 36.61% |
| ROCE | 37.65% |
| Debt/Equity | 0.15 |
| RoNW | 36.61% |
| PAT Margin | 23.61% |
| EBITDA Margin | 41.12% |
| Price to Book Value | 22.62 |
| EPS | 1.85 |
| P/E (x) | 61.62 |
| Promoter Holding | 99.10% |
Prospectus Links:
Prospectus: Official documents that provide detailed information about the IPO and the company.
Gujarat Kidney & Super Speciality IPO RHP
Gujarat Kidney & Super Speciality IPO DRHP

News Desk



